155 related articles for article (PubMed ID: 38546012)
1. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.
Castanon A; Bray BD; Ramagopalan SV
J Comp Eff Res; 2024 May; 13(5):e240033. PubMed ID: 38546012
[TBL] [Abstract][Full Text] [Related]
2. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2024 Jan; 13(1):e230189. PubMed ID: 38179957
[TBL] [Abstract][Full Text] [Related]
3. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 7.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jul; 11(10):699-701. PubMed ID: 35506497
[TBL] [Abstract][Full Text] [Related]
4. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2023 Jan; 12(1):e220194. PubMed ID: 36453665
[TBL] [Abstract][Full Text] [Related]
5. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 May; 11(7):473-475. PubMed ID: 35261285
[TBL] [Abstract][Full Text] [Related]
6. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2023 Nov; 12(11):e230141. PubMed ID: 37712636
[TBL] [Abstract][Full Text] [Related]
7. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Mar; 11(4):213-215. PubMed ID: 34989244
[TBL] [Abstract][Full Text] [Related]
8. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Nov; 11(16):1147-1149. PubMed ID: 35998008
[TBL] [Abstract][Full Text] [Related]
9. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Sep; 11(13):915-917. PubMed ID: 35703134
[TBL] [Abstract][Full Text] [Related]
10. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 3.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Nov; 10(16):1175-1176. PubMed ID: 34412538
[TBL] [Abstract][Full Text] [Related]
11. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Jul; 10(10):797-799. PubMed ID: 33955236
[TBL] [Abstract][Full Text] [Related]
12. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jan; 11(1):11-12. PubMed ID: 34702048
[TBL] [Abstract][Full Text] [Related]
13. R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Sep; 10(13):957-959. PubMed ID: 34184540
[TBL] [Abstract][Full Text] [Related]
14. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11.
Bray B; Ramagopalan SV
J Comp Eff Res; 2023 May; 12(5):e230008. PubMed ID: 37052075
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness research in radiation oncology: assessing technology.
Chen AB
Semin Radiat Oncol; 2014 Jan; 24(1):25-34. PubMed ID: 24314339
[TBL] [Abstract][Full Text] [Related]
16. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12.
Bray B; Ramagopalan SV
J Comp Eff Res; 2023 Jul; 12(7):e230092. PubMed ID: 37345541
[TBL] [Abstract][Full Text] [Related]
17. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Deverka PA; Douglas MP; Phillips KA
Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
[TBL] [Abstract][Full Text] [Related]
18. Examining the association between oncology drug clinical benefit and the time to public reimbursement.
Thomson S; Everest L; Witzke N; Jiao T; Delos Santos S; Nguyen V; Cheung MC; Chan KKW
Cancer Med; 2022 Jan; 11(2):380-391. PubMed ID: 34850587
[TBL] [Abstract][Full Text] [Related]
19. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
J Manag Care Spec Pharm; 2020 Dec; 26(12):1604-1611. PubMed ID: 33251991
[TBL] [Abstract][Full Text] [Related]
20. The use of real-world evidence in ICER's scoping process and clinical evidence assessments.
Jiao B; Veenstra DL; Lee W; Carlson JJ; Devine B
J Manag Care Spec Pharm; 2020 Dec; 26(12):1590-1595. PubMed ID: 33251999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
